Followers | 1071 |
Posts | 136199 |
Boards Moderated | 0 |
Alias Born | 08/25/2010 |
![](https://investorshub.advfn.com/uicon/215212.png?cb=1603206687)
Friday, April 16, 2021 8:48:18 AM
Regen BioPharma, Inc. announced drug discovery agreement with Eli Lilly and Company
Regen will receive compounds from Lilly for drug discovery purposes
deal_57752e848510c.jpg
As part of the deal, Regen will examine 21,000 Lilly-owned compounds
Shares in Regen BioPharma, Inc (OTCQB: RGBP, OTCQB: RGBPP) shot higher as the firm announced it had entered into a definitive agreement with Eli Lilly and Co (NYSE:LLY).
Regen will receive compounds from Lilly for drug discovery purposes, as well as share structural information on compounds.
It also paves the way for the two companies to negotiate future compound purchase agreements, license agreements, and research collaboration agreements.
“They understand the value of partnering in a confidential manner with smaller entities that may have intellectual property that aligns with their product goals,” Harry Lander, president and chief scientific officer of Regen said.
As part of the deal, Regen will examine 21,000 Lilly-owned compounds in its NR2F6 high-throughput screening program.
NR2F6 is a molecular switch known as an "orphan nuclear receptor," which controls genes associated with the immune response as well as genes associated with the ability of cancer stem cells to propagate.
Everything I say is in my opinion, do your own DD and make your decision wisely! Don't spend more then you can afford to lose!
FEATURED Cannabix Technologies to Deliver Innovative Breath Logix Alcohol Screening Device to Texas, USA • Jul 29, 2024 9:07 AM
INDEXR AI Merges With Moon Equity Holdings Corp. (MONI), Creating a Leading-edge Technology Company • MONI • Jul 29, 2024 9:59 AM
BNCM AND DELEX UNVEIL POST-MERGER MANAGEMENT PLANS • BNCM • Jul 29, 2024 9:00 AM
Glidelogic Corp. Announces Revolutionary AI-Generated Content Copyright Protection Solution • GDLG • Jul 26, 2024 12:30 PM
Southern Silver Files NI43-101 Technical Report for its Updated Preliminary Economic Assessment for the Cerro Las Minitas Project • SSV • Jul 25, 2024 8:00 AM
Greenlite Ventures Completes Agreement with No Limit Technology • GRNL • Jul 19, 2024 10:00 AM